Monsenso AS (MONSO) - Total Liabilities
Based on the latest financial reports, Monsenso AS (MONSO) has total liabilities worth Dkr6.07 Million DKK (≈ $950.32K USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Monsenso AS - Total Liabilities Trend (2015–2025)
This chart illustrates how Monsenso AS's total liabilities have evolved over time, based on quarterly financial data. See MONSO net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Monsenso AS Competitors by Total Liabilities
The table below lists competitors of Monsenso AS ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Mustang Bio Inc
NASDAQ:MBIO
|
USA | $7.99 Million |
|
NanoVibronix Inc
NASDAQ:NAOV
|
USA | $11.92 Million |
|
Fairchild Gold Corp
V:FAIR
|
Canada | CA$504.25K |
|
C&C Group plc
LSE:CCR
|
UK | GBX812.48 Million |
|
The GYM Group PLC
LSE:GYM
|
UK | GBX474.20 Million |
|
IDOX plc
LSE:IDOX
|
UK | GBX71.48 Million |
|
ACRUX Ltd
AU:ACR
|
Australia | AU$6.20 Million |
|
Simble Solutions Ltd
AU:SIS
|
Australia | AU$1.22 Million |
Liability Composition Analysis (2015–2025)
This chart breaks down Monsenso AS's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see how much is Monsenso AS worth.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.01 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.87 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.47 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Monsenso AS's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Monsenso AS (2015–2025)
The table below shows the annual total liabilities of Monsenso AS from 2015 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | Dkr6.07 Million ≈ $950.32K |
+40.41% |
| 2024-12-31 | Dkr4.33 Million ≈ $676.83K |
-46.01% |
| 2023-12-31 | Dkr8.01 Million ≈ $1.25 Million |
+94.63% |
| 2022-12-31 | Dkr4.12 Million ≈ $644.13K |
-26.63% |
| 2021-12-31 | Dkr5.61 Million ≈ $877.88K |
-43.61% |
| 2020-12-31 | Dkr9.95 Million ≈ $1.56 Million |
+30.83% |
| 2019-12-31 | Dkr7.61 Million ≈ $1.19 Million |
-19.10% |
| 2018-12-31 | Dkr9.40 Million ≈ $1.47 Million |
-16.41% |
| 2017-12-31 | Dkr11.25 Million ≈ $1.76 Million |
+167.14% |
| 2016-12-31 | Dkr4.21 Million ≈ $658.65K |
-5.36% |
| 2015-12-31 | Dkr4.45 Million ≈ $695.99K |
-- |
About Monsenso AS
Monsenso A/S develops and sells digital health solution for the treatment of depression, bipolar disorder, anxiety, schizophrenia, borderline personality disorder, and addiction and substance abuse in Denmark. The company offers Monsenso app for individuals that collects patient-reported and sensor data providing insights into symptoms, adherence, and outcomes. It also provides Monsenso solution,… Read more